Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 20-1082179 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Accelerate the Discovery of drugs to prevent and treat Alzheimer's disease and related dementias.
Principal Officer
Howard Fillit MD
Total Revenue
$47.3M
FY2024
Total Expenses
$88.3M
FY2024
Net Assets
$217.0M
Program Ratio
92.7%
expenses on programs
Employees
48
Volunteers
28
Board Members
29
Voting
28
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.